Presentation Cost-Effectiveness of Revascularization Strategies: The ASCERT Study Presenter: Zugui Zhang January 08, 2015
News Daily News Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe December 04, 2014
News Daily News Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease L.A. McKeown November 20, 2014
News Daily News Meta-analysis Confirms Benefits of FFR-Guided Revascularization Yael L. Maxwell October 24, 2014
News Daily News Un Estudio Sugiere que el Cierre del FOP Podría ser Rentable a Largo Plazo Yael L. Maxwell October 03, 2014
News Daily News Study Suggests PFO Closure May Be Cost-Effective Over Long Term Yael L. Maxwell October 03, 2014
Presentation Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke Presenter: Christopher A. Pickett September 30, 2014
Presentation TCT 2014 Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation Presenter: Vivian Lee September 16, 2014
News Industry News Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease September 16, 2014
News Conference News TCT 2014 First TCT Innovation Award Given for Novel Cooling System September 16, 2014
Presentation TCT 2014 TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee September 15, 2014
News Conference News TCT 2014 Economics May Lead to Shift in Process of Innovation September 15, 2014
News Conference News TCT 2014 LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF September 14, 2014
Presentation TCT 2014 Cost-effectiveness of Antiproliferative Therapies for Claudication Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Michael R. Jaff September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
News Conference News TCT 2014 TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost Todd Neale September 13, 2014
News Industry News New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients September 13, 2014
News Industry News Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients September 13, 2014
Presentation Clinical Outcomes and Cost-Effectiveness of Initial Treatment Strategies for Nonembolic Acute Limb Ischemia in Real-Life Clinical Settings Presenter: Fedor Lurie September 08, 2014